| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |